Lantheus annuncia l’acquisizione di Evergreen Theragnostics. Exit nel settore dei radiofarmaci per LIFTT Your browser does not seem to support iframes. Click here to read this PDF.Your browser does not seem to support iframes. Click here to read this PDF. Created using FlowPaper Flipbook Maker ↗ LIFTT Venture Capital Italia2025-01-28T18:32:31+01:0028 Gennaio 2025| Share FacebookXLinkedInWhatsAppEmail